Long-term remission and survival in patients with relapsed or refractory multiple myeloma after treatment with LCAR-B38M CAR T cells: 5-year follow-up of the LEGEND-2 trial.

Autor: Xu, Jie¹ (AUTHOR), Wang, Bai-Yan² (AUTHOR), Yu, Shan-He¹ (AUTHOR), Chen, Shi-Jun¹ (AUTHOR), Yang, Shuang-Shuang¹ (AUTHOR), Liu, Rui² (AUTHOR), Chen, Li-Juan³ (AUTHOR), Hou, Jian⁴ (AUTHOR), Chen, Zhu¹ (AUTHOR), Zhao, Wan-Hong² (AUTHOR) 13991365406@163.com, He, Ai-Li² (AUTHOR) heaili@xjtu.edu.cn, Mi, Jian-Qing¹ (AUTHOR) jianqingmi@shsmu.edu.cn, Chen, Sai-Juan¹ (AUTHOR) sjchen@stn.sh.cn

Publikováno v: Journal of Hematology & Oncology. 4/24/2024, Vol. 17, p1-13. 13p.

Five-year remission without disease progression in a patient with relapsed/refractory multiple myeloma with extramedullary disease treated with LCAR-B38M chimeric antigen receptor T cells in the LEGEND-2 study: a case report.

Autor: Wang, Bai-Yan¹ (AUTHOR), Zhao, Wan-Hong¹ (AUTHOR), Chen, Yin-Xia¹ (AUTHOR), Cao, Xing-Mei¹ (AUTHOR), Yang, Yun¹ (AUTHOR), Zhang, Yi-Lin¹ (AUTHOR), Wang, Fang-Xia² (AUTHOR), Zhang, Peng-Yu¹ (AUTHOR), Lei, Bo¹ (AUTHOR), Gu, Liu-Fang¹ (AUTHOR), Wang, Jian-Li¹ (AUTHOR), Bai, Ju¹ (AUTHOR), Xu, Yan¹ (AUTHOR), Wang, Xu-Geng¹ (AUTHOR), Zhang, Rui-Li¹ (AUTHOR), Wei, Li-Li¹ (AUTHOR), Zhuang, Qiu-Chuan³ (AUTHOR), Fan, Frank³ (AUTHOR), Zhang, Wang-Gang¹ (AUTHOR), He, Ai-Li⁴ (AUTHOR)

Publikováno v: Journal of Medical Case Reports. 12/11/2022, Vol. 16 Issue 1, p1-8. 8p.

Genomic Profiling of Adult and Pediatric B-cell Acute Lymphoblastic Leukemia

Autor: Liu, Yuan-Fang, Wang, Bai-Yan, Zhang, Wei-Na, Huang, Jin-Yan, Li, Ben-Shang, Zhang, Ming, Jiang, Lu, Li, Jian-Feng, Wang, Ming-Jie, Dai, Yu-Jun, Zhang, Zi-Guan, Wang, Qiang, Kong, Jie, Chen, Bing, Zhu, Yong-Mei, Weng, Xiang-Qin, Shen, Zhi-Xiang, Li, Jun-Min, Wang, Jin, Yan, Xiao-Jing, Li, Yan, Liang, Ying-Min, Liu, Li, Chen, Xie-Qun, Zhang, Wang-Gang, Yan, Jin-Song, Hu, Jian-Da, Shen, Shu-Hong, Chen, Jing, Gu, Long-Jun, Pei, Deqing, Li, Yongjin, Wu, Gang, Zhou, Xin, Ren, Rui-Bao, Cheng, Cheng, Yang, Jun J., Wang, Kan-Kan, Wang, Sheng-Yue, Zhang, Jinghui, Mi, Jian-Qing, Pui, Ching-Hon, Tang, Jing-Yan, Chen, Zhu, Chen, Sai-Juan

Publikováno v: In EBioMedicine June 2016 8:173-183

Additional file 1 of Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2)

Autor: Zhao, Wan-Hong, Wang, Bai-Yan, Chen, Li-Juan, Fu, Wei-Jun, Xu, Jie, Liu, Jie, Jin, Shi-Wei, Chen, Yin-Xia, Cao, Xing-Mei, Yang, Yun, Zhang, Yi-Lin, Wang, Fang-Xia, Zhang, Peng-Yu, Lei, Bo, Gu, Liu-Fang, Wang, Jian-Li, Zhang, Hui, Bai, Ju, Xu, Yan, Zhu, Han, Du, Juan, Jiang, Hua, Fan, Xiao-Hu, Li, Jian-Yong, Hou, Jian, Chen, Zhu, Zhang, Wang-Gang, Mi, Jian-Qing, Chen, Sai-Juan, He, Ai-Li

Additional file1: Fig. S1. Study Design. Fig. S2. A Duration of response, B overall survival, and C progression-free survival by cytogenetic risk. Fig. S3. Relationship of duration of response with A sBCMA, B transgene persistence, and C antidrug ant

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10494fbfbdf7b3a4d654c6fbde0870b1

Peptide-based immunotherapy for multiple myeloma: Current approaches

Autor: Zhou, Fu-ling, Meng, Shan, Zhang, Wang-gang, Wei, Yong-chang, Cao, Xing-mei, Bai, Gai-gai, Wang, Bai-yan

Publikováno v: In Vaccine 2010 28(37):5939-5946